21. Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers. Issue 6 (19th May 2020) Authors: Suzuki, Susumu; Ogawa, Tetsuya; Sano, Rui; Takahara, Taishi; Inukai, Daisuke; Akira, Satou; Tsuchida, Hiromi; Yoshikawa, Kazuhiro; Ueda, Ryuzo; Tsuzuki, Toyonori Journal: Cancer science Issue: Volume 111:Issue 6(2020) Page Start: 1943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma. (6th October 2020) Authors: Fujii, Keiichiro; Sakamoto, Yuma; Masaki, Ayako; Murase, Takayuki; Tashiro, Yukie; Yonekura, Kentaro; Utsunomiya, Atae; Ito, Asahi; Kusumoto, Shigeru; Iida, Shinsuke; Ueda, Ryuzo; Ishida, Takashi; Inagaki, Hiroshi Journal: Journal of pathology Issue: Volume 7:Number 1(2021) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma. Issue 10 (2nd August 2021) Authors: Kondo, Yutaro; Suzuki, Susumu; Takahara, Taishi; Ono, Shoya; Goto, Mitsuo; Miyabe, Satoru; Sugita, Yoshihiko; Ogawa, Tetsuya; Ito, Hideaki; Satou, Akira; Tsuzuki, Toyonori; Yoshikawa, Kazuhiro; Ueda, Ryuzo; Nagao, Toru Journal: Cancer science Issue: Volume 112:Issue 10(2021) Page Start: 4037 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Increased infiltration of CCR4‐positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis. Issue 14 (7th August 2019) Authors: Watanabe, Masahito; Kanao, Kent; Suzuki, Susumu; Muramatsu, Hiroyuki; Morinaga, Singo; Kajikawa, Keishi; Kobayashi, Ikuo; Nishikawa, Genya; Kato, Yoshiharu; Zennami, Kenji; Nakamura, Kogenta; Tsuzuki, Toyonori; Yoshikawa, Kazuhiro; Ueda, Ryuzo; Sumitomo, Makoto Journal: Prostate Issue: Volume 79:Issue 14(2019) Page Start: 1658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies. Issue 10 (28th August 2017) Authors: Ishida, Takashi; Utsunomiya, Atae; Jo, Tatsuro; Yamamoto, Kazuhito; Kato, Koji; Yoshida, Shinichiro; Takemoto, Shigeki; Suzushima, Hitoshi; Kobayashi, Yukio; Imaizumi, Yoshitaka; Yoshimura, Kenichi; Kawamura, Kouichi; Takahashi, Takeshi; Tobinai, Kensei; Ueda, Ryuzo Journal: Cancer science Issue: Volume 108:Issue 10(2017) Page Start: 2022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Over one‐third of African‐American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg‐7, an autosomal dominantly inherited risk factor for MGUS/MM. Issue 4 (4th February 2014) Authors: Zwick, Carsten; Held, Gerhard; Auth, Michaela; Bernal‐Mizrachi, Leon; Roback, John D.; Sunay, Susan; Iida, Shinsuke; Kuroda, Yoshiaki; Sakai, Akira; Ziepert, Marita; Ueda, Ryuzo; Pfreundschuh, Michael; Preuss, Klaus‐Dieter Journal: International journal of cancer Issue: Volume 135:Issue 4(2014:Aug. 15) Page Start: 934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma. Issue 10 (4th September 2017) Authors: Maruyama, Dai; Nagai, Hirokazu; Maeda, Yoshinobu; Nakane, Takahiko; Shimoyama, Tatsu; Nakazato, Tomonori; Sakai, Rika; Ishikawa, Takayuki; Izutsu, Koji; Ueda, Ryuzo; Tobinai, Kensei Journal: Cancer science Issue: Volume 108:Issue 10(2017) Page Start: 2061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy. Issue 5 (18th March 2021) Authors: Yamauchi, Nobuhiko; Maruyama, Dai; Choi, Ilseung; Atsuta, Yoshiko; Sakai, Rika; Miyashita, Kazuho; Moriuchi, Yukiyoshi; Tsujimura, Hideki; Kubota, Nobuko; Yamamoto, Go; Igarashi, Tadahiko; Izutsu, Koji; Yoshida, Shinichiro; Kojima, Kensuke; Uchida, Toshiki; Inoue, Yoshiko; Tsukamoto, Norifumi; Oh... Journal: Cancer science Issue: Volume 112:Issue 5(2021) Page Start: 1943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Reactivation of hepatitis B virus in a patient with adult T‐cell leukemia–lymphoma receiving the anti‐CC chemokine receptor 4 antibody mogamulizumab. Issue 3 (18th April 2013) Authors: Nakano, Nobuaki; Kusumoto, Shigeru; Tanaka, Yasuhito; Ishida, Takashi; Takeuchi, Shogo; Takatsuka, Yoshifusa; Akinaga, Shiro; Mizokami, Masashi; Ueda, Ryuzo; Utsunomiya, Atae Journal: Hepatology research Issue: Volume 44:Issue 3(2014:Mar.) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma. Issue 10 (19th September 2019) Authors: Maekawa, Keiko; Ri, Masaki; Nakajima, Miki; Sekine, Akihiro; Ueda, Ryuzo; Tohkin, Masahiro; Miyata, Naoki; Saito, Yoshiro; Iida, Shinsuke Journal: Cancer science Issue: Volume 110:Issue 10(2019) Page Start: 3267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗